Development and optimization of a solid dispersion hot-melt fluid bed coating method

Pharmaceutical Development and Technology
J P Kennedy, P J Niebergall

Abstract

A new hot-melt fluid bed coating process has been developed, characterized, and optimized. Polyethylene glycol served as the model coating agent and was charged with substrate into the fluid bed chamber in the solid state. The processing stages included: (A) warm-up, (B) preheating, (C) melting-spreading, and (D) cooling-congealing. A central composite design was utilized to characterize and optimize the process. Substrate porosity and density evaluations were conducted by mercury intrusion. The method proved capable of coating nonpareils from 10 to 35 mesh (0.500 to 2.00 mm) and tablets up to 1 g. The nonpareils were coated as individual particles, while particle sizes significantly smaller than 40 mesh (0.420 mm) tended to agglomerate. The porosity and density values of dissimilar nonpareil batches showed a large degree of variation, affecting the method's reproducibility. Additive coatings were achieved by sequential runs using coating agents of diminishing melting points. The method is a viable alternative to hot-melt spray-coating processes. Organic solvents, spraying equipment, steam jackets, and/or heating tape are eliminated from the process.

References

Apr 1, 1978·Journal of Pharmaceutical Sciences·S Motycka, J G Nairn
Nov 1, 1990·Pharmaceutical Research·M J JozwiakowskiR M Franz
Apr 1, 1968·Journal of Pharmaceutical Sciences·P M John, C H Becker

❮ Previous
Next ❯

Citations

Jun 27, 2006·AAPS PharmSciTech·Paulus SeitavuopioJouko Yliruusi
Nov 18, 1998·Journal of Microencapsulation·B J LeeC K Kim
Nov 24, 2004·Drug Development and Industrial Pharmacy·Lorenzo RodriguezLorella Giovannelli
Oct 24, 2012·International Journal of Pharmaceutics·Vincent Jannin, Yvonne Cuppok
Nov 30, 2007·Advanced Drug Delivery Reviews·V JanninD Marchaud
May 19, 2007·Pharmaceutical Development and Technology·Sagarika Bose, Robin H Bogner
Jun 22, 2001·Pharmaceutical Development and Technology·Y E ZhangJ B Schwartz
Aug 1, 1997·Pharmaceutical Development and Technology·J P Kennedy, P J Niebergall
Apr 9, 1998·Pharmaceutical Development and Technology·P S WaliaR Turton
Feb 23, 1999·Pharmaceutical Development and Technology·E N Griffin, P J Niebergall
Jan 18, 2013·Pharmaceutical Development and Technology·Loan Pham, John M Christensen
Mar 20, 2015·Pharmaceutical Research·Karin BeckerAndreas Zimmer
Jan 20, 2007·AAPS PharmSciTech·Hamsaraj KaranthRayasa Ramachandra Murthy
Jul 15, 2017·Drug Development and Industrial Pharmacy·Anastasia Anna FoppoliAndrea Gazzaniga
Aug 14, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Işık Sena Akgün, Can Erkey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Paulus SeitavuopioJ Yliruusi
© 2022 Meta ULC. All rights reserved